Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eomesodermin (EOMES) is a T-box transcription factor essential in early mammalian embryogenesis and immune cell lineage specification. In embryonic development, it plays a pivotal role in specifying extraembryonic lineages such as the trophectoderm and in the sequential specification of mesodermal derivatives required for heart, yolk sac, and endoderm formation[1][2]. EOMES regulates the maintenance of trophoblast stem cells, supports epithelial to mesenchymal transition, and partners with other transcription factors and chromatin-modifying complexes to maintain chromatin accessibility at lineage-specific genes[1]. In the immune system, EOMES is critical for the differentiation, effector functions, and memory formation of CD8+ T lymphocytes, integrating extracellular signals and driving expression of genes such as interferon-γ, perforin, and granzyme B[3]. Disruption of EOMES leads to developmental arrest in embryos and can skew immune cell fate decisions, underlining its essential regulatory roles across multiple biological contexts[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eomesodermin (EOMES).